149 related articles for article (PubMed ID: 27764650)
1. High chlamydia and gonorrhoea repeat positivity in remote Aboriginal communities 2009-2011: longitudinal analysis of testing for re-infection at 3 months suggests the need for more frequent screening.
Garton L; Dyda A; Guy R; Silver B; McGregor S; Hengel B; Rumbold A; Taylor-Thomson D; Knox J; Maher L; Kaldor J; Ward J;
Sex Health; 2016 Nov; 13(6):568-574. PubMed ID: 27764650
[TBL] [Abstract][Full Text] [Related]
2. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the "TTANGO" trial protocol.
Guy RJ; Natoli L; Ward J; Causer L; Hengel B; Whiley D; Tabrizi SN; Donovan B; Fairley CK; Badman SB; Tangey A; Wand H; Shephard M; Regan DG; Wilson D; Anderson D; Kaldor JM
BMC Infect Dis; 2013 Oct; 13():485. PubMed ID: 24138699
[TBL] [Abstract][Full Text] [Related]
3. Coinfection with Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis: a cross-sectional analysis of positivity and risk factors in remote Australian Aboriginal communities.
Guy R; Ward J; Wand H; Rumbold A; Garton L; Hengel B; Silver B; Taylor-Thomson D; Knox J; McGregor S; Dyda A; Fairley C; Maher L; Donovan B; Kaldor J;
Sex Transm Infect; 2015 May; 91(3):201-6. PubMed ID: 25352691
[TBL] [Abstract][Full Text] [Related]
4. Incidence of curable sexually transmissible infections among adolescents and young adults in remote Australian Aboriginal communities: analysis of longitudinal clinical service data.
Silver BJ; Guy RJ; Wand H; Ward J; Rumbold AR; Fairley CK; Donovan B; Maher L; Dyda A; Garton L; Hengel B; Knox J; McGregor S; Taylor-Thomson D; Kaldor JM;
Sex Transm Infect; 2015 Mar; 91(2):135-41. PubMed ID: 25371420
[TBL] [Abstract][Full Text] [Related]
5. Patient, staffing and health centre factors associated with annual testing for sexually transmissible infections in remote primary health centres.
Hengel B; Wand H; Ward J; Rumbold A; Garton L; Taylor-Thomson D; Silver B; McGregor S; Dyda A; Mein J; Knox J; Maher L; Kaldor J; Guy R;
Sex Health; 2017 Jun; 14(3):274-281. PubMed ID: 28445684
[TBL] [Abstract][Full Text] [Related]
6. A sexual health quality improvement program (SHIMMER) triples chlamydia and gonorrhoea testing rates among young people attending Aboriginal primary health care services in Australia.
Graham S; Guy RJ; Wand HC; Kaldor JM; Donovan B; Knox J; McCowen D; Bullen P; Booker J; O'Brien C; Garrett K; Ward JS
BMC Infect Dis; 2015 Sep; 15():370. PubMed ID: 26329123
[TBL] [Abstract][Full Text] [Related]
7. Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial.
Guy RJ; Ward J; Causer LM; Natoli L; Badman SG; Tangey A; Hengel B; Wand H; Whiley D; Tabrizi SN; Shephard M; Fairley CK; Donovan B; Anderson DA; Regan DG; Maher L; Kaldor JM
Lancet Infect Dis; 2018 Oct; 18(10):1117-1126. PubMed ID: 30303108
[TBL] [Abstract][Full Text] [Related]
8. Analysis of diagnostic data for sexually transmissible infections in South Australian Aboriginal Community Controlled Health Services (2008-16).
Elliott SR; Betts S; Hobbs K; Wand H; Rumbold AR; Ward J; Johnson DR
Sex Health; 2019 Nov; 16(6):566-573. PubMed ID: 31623703
[TBL] [Abstract][Full Text] [Related]
9. Retesting and repeat positivity following diagnosis of Chlamydia trachomatis and Neisseria gonorrhoea in New Zealand: a retrospective cohort study.
Rose SB; Garrett SM; Stanley J; Pullon SRH
BMC Infect Dis; 2017 Jul; 17(1):526. PubMed ID: 28754106
[TBL] [Abstract][Full Text] [Related]
10. Gonorrhoea testing and positivity in non-remote Aboriginal Community Controlled Health Services.
Harrod ME; Couzos S; Ward J; Saunders M; Donovan B; Hammond B; Delaney-Thiele D; Belfrage M; Williams S; Smith LW; Kaldor JM
Sex Health; 2017 Aug; 14(4):320-324. PubMed ID: 28641073
[TBL] [Abstract][Full Text] [Related]
11. Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation.
Causer LM; Guy RJ; Tabrizi SN; Whiley DM; Speers DJ; Ward J; Tangey A; Badman SG; Hengel B; Natoli LJ; Anderson DA; Wand H; Wilson D; Regan DG; Shephard M; Donovan B; Fairley CK; Kaldor JM
Sex Transm Infect; 2018 Aug; 94(5):340-345. PubMed ID: 29748180
[TBL] [Abstract][Full Text] [Related]
12. Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.
Natoli L; Guy RJ; Shephard M; Whiley D; Tabrizi SN; Ward J; Regan DG; Badman SG; Anderson DA; Kaldor J; Maher L;
BMJ Open; 2015 Apr; 5(4):e006922. PubMed ID: 25922100
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive overview of urogenital, anorectal and oropharyngeal Neisseria gonorrhoeae testing and diagnoses among different STI care providers: a cross-sectional study.
den Heijer CDJ; Hoebe CJPA; van Liere GAFS; van Bergen JEAM; Cals JWL; Stals FS; Dukers-Muijrers NHTM
BMC Infect Dis; 2017 Apr; 17(1):290. PubMed ID: 28427377
[TBL] [Abstract][Full Text] [Related]
14. Get Yourself Tested 2011-2012: findings and prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae at an urban public health system.
Roston A; Suleta K; Stempinski K; Keith L; Patel A
Int J STD AIDS; 2015 Apr; 26(5):322-8. PubMed ID: 24867819
[TBL] [Abstract][Full Text] [Related]
15. Trends in chlamydia and gonorrhoea testing and positivity in Western Australian Aboriginal and non-Aboriginal women 2001-2013: a population-based cohort study.
Reekie J; Donovan B; Guy R; Hocking JS; Kaldor JM; Mak DB; Pearson S; Preen D; Wand H; Ward J; Liu B;
Sex Health; 2017 Nov; 14(6):574-580. PubMed ID: 28648150
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.
Natoli L; Maher L; Shephard M; Hengel B; Tangey A; Badman SG; Ward J; Guy RJ;
PLoS One; 2014; 9(6):e100518. PubMed ID: 24956111
[TBL] [Abstract][Full Text] [Related]
17. Community and clinic-based screening for curable sexually transmissible infections in a high prevalence setting in Australia: a retrospective longitudinal analysis of clinical service data from 2006 to 2009.
Silver B; Kaldor JM; Rumbold A; Ward J; Smith K; Dyda A; Ryder N; Yip TW; Su JY; Guy RJ
Sex Health; 2016 Apr; 13(2):140-7. PubMed ID: 26678863
[TBL] [Abstract][Full Text] [Related]
18. Value of repeat testing using Cepheid GeneXpert CT/NG for indeterminate PCR results when diagnosing Chlamydia trachomatis and Neisseria gonorrhoeae.
Parcell BJ; Ratnayake L; Kaminski G; Olver WJ; Yirrell DL
Int J STD AIDS; 2015 Jan; 26(1):65-7. PubMed ID: 24810211
[TBL] [Abstract][Full Text] [Related]
19. Rectal Infection With Neisseria gonorrhoeae and Chlamydia trachomatis in Men in the United States.
Tao G; Hoover KW; Nye MB; Peters P; Gift TL; Peruvemba R; Body BA
Clin Infect Dis; 2016 Nov; 63(10):1325-1331. PubMed ID: 27572098
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia sentinel surveillance in Aboriginal Community Controlled Health Services finds higher testing and positivity rates among younger people.
Goller JL; Ward J; Saunders M; Couzos S; Kaldor J; Hellard MA;
Aust N Z J Public Health; 2012 Dec; 36(6):577-81. PubMed ID: 23216501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
